Available Guidance and Best Practices for Conducting Forced Degradation Studies

Author(s)Dan W. Reynolds, PhD, Karen M. Alsante, PhD, Kevin L. Facchine, PhD

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.

External Link - article-9668.pdf

Articles in this issue

over 24 years ago

Article

Using Earned-Value Analysis to Better Manage Projects

over 24 years ago

Article

Microbial Bioburden on Oral Solid Dosage Forms

over 24 years ago

Article

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I

over 24 years ago

Article

Modernizing Pharmaceutical Manufacturing

over 24 years ago

Article

The Role of Computational Fluid Dynamics in the Pharmaceutical Industry

over 24 years ago

Article

Outsourcing Outlook

over 24 years ago

Article

Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble Drug

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.